To examine the motor cortical control of antagonist muscle function in younger and older adults
ID
Source
Brief title
Condition
- Other condition
Synonym
Health condition
Veroudering
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The primary study parameter is the co-activation of antagonist muscle function
in younger and older adults during a rapid flexion of the wrist after hearing
an auditory tone.
Secondary outcome
The secondary study parameter is the amount of motor cortical excitability
before and during the flexion of the hand in younger and older adults.
Background summary
There is overwhelming evidence that for some reason increasing age affects a
key aspect of how humans produce voluntary force. During finger, wrist, elbow,
knee, and ankle joint movements old compared with young adults execute weak and
strong contractions so that the muscle that is antagonist (opposing) to the
muscle that produces the movement (the agonist), becomes more strongly
activated. The neural mechanism of this age-related increase in coactivation is
unknown. One example for the functional significance of this age-driven altered
movement strategy is the strong association between the 20% greater metabolic
cost of transport and heightened antagonist leg muscle activation during gait
in old compared with young adults. The hypothesis is that motor cortical
control of antagonist muscle function alters with age.
Study objective
To examine the motor cortical control of antagonist muscle function in younger
and older adults
Study design
In this study, a rapid flexion of the wrist will be used as a voluntary
movement to examine the amount of coactivation in the lower arm muscles. The
cortical excitability before and during the movement will be measured with
transcranial magnetic stimulation (TMS).
Participants respond to a tone by rapidly flexing their right-dominant wrist. A
single TMS is given with 20 ms increments between 80 to 380 ms after the tone.
Pilot experiments showed that old individuals were able to reliably execute the
reaction time task if administered in 3 blocks of 68 trials, a total of 204
trials with 3-5 minutes of rest between the blocks. In 1 of the 17 conditions,
only the tone is presented and in the 16 other time-interval conditions a
single TMS pulse is delivered, targeting the right wrist muscles. There are 12
trials in each of the 17 conditions, with the condition administered in a
random order. The data are then sorted in to 10 ms bins. The participants will
visit the Center for human movement sciences once during an approximately 2
hour lasting session.
Intervention
Non-invasive flexion of the right hand after hearing an auditory tone.
Measuring the cortical excitability indexed by the size of the motor evoked
potentials (MEPs) produced by transcranial magnetic stimulation (TMS).
Study burden and risks
Participants will visit the Center for Human Movements Sciences once. The
duration of the session is approximately 2 hours. TMS may cause slight
discomfort lasting less than a second on the scalp near the coil. It may also
cause twitching of the muscles, the face and jaw, which may be unpleasant and
surprising but not painful. There are no known long-term risks of magnetic
brain stimulation. For participating in the study, participants receive 10
euros in form of VVV gift cards.
Antonius Deusinglaan 1
Groningen 9700AD
NL
Antonius Deusinglaan 1
Groningen 9700AD
NL
Listed location countries
Age
Inclusion criteria
Age 18-30 years or 65>, female or male gender, right-handed
Exclusion criteria
Fracture in the upper extremity over the past year, having neurological disorders, being pregnant, muscle or joint disorders, cardiovasculair diseases, medicine known to affect nerve conduction, a history of epilepsy, use of a pacemaker, and metal in the brain/skull
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
In other registers
Register | ID |
---|---|
CCMO | NL52432.042.15 |
OMON | NL-OMON23489 |